CONCLUSION
AND
PERSPECTIVES
Patrick Marcellin
Who you are
1037 participants from 68 countries
Progress is accelerating
The conclusion of PHC 2009
 Cure = 100% in 10 years
Progress is accelerating
The conclusion of PHC 2012
Cure = 100% in 5 years
ACCESS TO TREATMENT:
SCREENING
ACCESS TO CURE
100
80
60
40
20
0
Catégorie
1
Treated
Diagnosed Managed
Cured
THE FUTURE TREATMENT
 100% efficacy
 All oral
 Short duration
 No resistance
 Pan-genotypic
 Well tolerated and safe
 Low cost
THE FUTURE
?
?
100% efficacy
All oral
Short duration
No resistance
Pan-genotypic
Well tolerated and safe
Low cost
PERSPECTIVAS
THE FUTURE?
PERSPECTIVAS
ONE PILL A DAY?
THE END
PHC 2012
FACULTY
NEZAM AFDHAL
ANTONIO CRAXI
OLIVIER LADA
RAJENDER REDDY
ALESSIO AGHEMO
VICTOR DE LEDINGHEN
GEORGE LAU
DIDIER SAMUEL
ALFREDO ALBERTI
GEOFFREY DUSHEIKO
SAM LEE
CHRISTOPH SARRAZIN
NABIL ANTAKI
GAMAL ESMAT
VINCENT LEROY
EUGENE SCHIFF
TARIK ASSELAH
RAPHAEL ESTEBAN
MASSIMO LEVRERO
RAYMOND SCHINAZI
BRUCE BACON
SHERIF FATTAH
JAKE LIANG
LAWRENCE SERFATY
RALF BARTENSCHLAGER
PETER FERENCI
ALESSANDRA MANGIA
MITCHELL SHIFFMAN
PIERRE BEDOSSA
ROBERT FLISIAK
MICHAEL MANNS
MARK SULKOWSKI
NAJET BEL HADJ BRIK
GRAHAM FOSTER
PHILIPPE MATHURIN
MARK THURSZ
MUSTAPHA BENNAZZOUZ
MICHAEL FRIED
RAMI MOUCARI
ALBERT TRAN
MARINA BERENGUER
PHILIPPE HALFON
FRANCESCO NEGRO
CHRISTIAN TREPO
MARC BOURLIERE
CHRISTOPHE HEZODE
DAVID NELSON
DOMINIQUE VALLA
JEAN-PIERRE
BRONOWICKI
JAY HOOFNAGLE
MASAO OMATA
MIHAI VOICULESCU
MARIA BUTI
ANDRZEJ HORBAN
RACHID OULD GOUGAM
IMAN WAKED
PAUL CALES
IRA JACOBSON
DENIS OUZAN
OLA WEILAND
ANA-CAROLINA CARDOSO
DONALD JENSEN
GEORGE
PAPATHEODORIDIS
CIHAN YURDAYDIN
LAURENT CASTERA
JI-DONG JIA
TEERHA PIRATVISUTH
JEAN-PIERRE ZARSKI
MASSIMO COLOMBO
JIA-HORNG KAO
STANISLAS POL
STEPHAN ZEUZEM
PATRICE COUZIGOU
PAUL KWO
VLAD RATZIU
FABIEN ZOULIM
Thanks to Sam Lee,
Tarik Asselah, Serge
Erlinger and Dale Roche
Slides on line
www.aphc.info
Unrestricted
educational grants
from:
Roche (founding
sponsor)
Merck Sharp and
Dohme
Janssen